Skip Navigation
Newsroom

Company news

Business
25 March 2021

Alvotech disputes AbbVie’s allegations of wrongdoing

Alvotech strongly disputes AbbVie’s allegations of wrongdoing relating to AVT02, Alvotech’s proposed biosimilar to HUMIRA® (adalimumab).

Business
15 March 2021

Alvotech completes second round of a US$ 100m private placement

Charity
05 March 2021

Alvotech and sister company Alvogen donate 100 thousand US dollars to UNICEF in combat against COVID-19

Business
02 March 2021

Cipla Gulf and Alvotech expand partnership for commercialization of biosimilars in Australia and New Zealand

Business
25 February 2021

Alvotech Iceland receives Equal Pay Certification

Business
30 December 2020

Ground-breaking for the extension of Alvotech's high-tech centre in Reykjavik

Business
10 December 2020

Alvotech and Fuji Pharma extend biosimilar partnership in Japan

Business
24 November 2020

Alvotech, Alvotech & CCHT Biopharmaceutical and Yangtze River Pharmaceutical agree on an exclusive biosimilar partnership in China

Business
19 November 2020

Alvotech announces that the U.S. FDA and EMA have accepted regulatory submissions for AVT02, a proposed biosimilar to Humira® (adalimumab)

Business
04 November 2020

Alvotech and Cipla partner to ensure access to biosimilars in South Africa

Business
27 October 2020

Alvotech announces private placement financing

Business
22 September 2020

Alvotech and DKSH extend partnership in Asia

Business
05 August 2020

Alvotech and Teva announce strategic partnership to collaborate in the U.S. biosimilar market

Tanya Zharov
People
18 May 2020

Tanya Zharov joins Alvotech as Deputy CEO

Business
12 May 2020

Alvotech announces positive top-line results for two comparative studies for AVT02, a proposed biosimilar to HUMIRA® (adalimumab)

Business
05 May 2020

Alvotech and Alvogen launch new B2B business brand

Business
24 March 2020

Delivering on our promise during the Coronavirus Pandemic

Business
24 March 2020

Alvotech and DKSH partner to bring key biosimilar to Asia

Business
14 January 2020

Alvotech and JAMP Pharma enter into an exclusive partnership for the commercialization of key biosimilars in Canada

Media Contact

Elisabet Hjaltadottir

Corporate Marketing & Communication